(MENAFN- Comserve)
Shibuya-ku, Tokyo, Japan, Japan, Dec 06, 2021, 05:55 /Comserve / -- This report enables Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers.
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report covers all the drugs that are in various phases of development (Discovery, Preclinical and Clinical). The pipeline focuses on novel pharmacologic drugs and regenerative medicines covering, antibodies, stem cell therapies, recombinant proteins, Peptide therapies, RNA-based therapeutics and others, but excludes symptom relief drugs, wound dressing, drug delivery systems, generic combinations and radiation therapies. The report also covers some of the hot targets in research for DFU treatments and related biomarkers.
This report enables Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the DFU drugs market . The report also provide strategic insights on some of the molecules that are yet to be launched in the next few years.
Request to Fill The Form To get Sample Copy of This Report:
Some of the key sections covered in the report are given below:
DFU Introduction
DFU grading, Treatment algorithm, Patient care pathway & Visiting patterns, Clinical practice guidelines, Current SOC, Adjuvant therapies, Alternative approaches, Unmet needs, ICD/CPT codes
Epidemiology
In this section, epidemiology of DFU is reviewed to understand potential significance and impact of the disease.
Global and US prevalence rates
Hot Targets, Pathophysiology and Biomarkers
In this section, various DFU associated targets, pathophysiology, and biomarkers are discussed. Also, covers novel targets in early research for DFU.
Market Data
Forecasting model for DFU market
DFU market dynamics
DFU Market Sizing
DFU related deals & Funding scenario in DFU market
Pipeline Analysis
Pipeline analysis was carried to get deeper insights on various treatment modalities in discovery, preclinical and development section, pipelines from major companies were identified and potential targets were reported along with Mechanism of action, Current development status and nature of molecule. Pipeline analysis by developmental stage (Discovery to Clinical development).
Small Molecules
Large Molecules
Stem Cell therapies, Protein therapies , Peptide therapies and Others
Drug analysis based on mechanism (Wound healing, Neuropathy, Ischemia, Neuroischemia and infection)
Key Players Analysis
The key player's analysis section provides an in-depth understanding of various companies working on DFU and their pipelines with development phase as well as understanding partnering strategies such as deals entered by the company.
Global key players overview
Global key players Pipeline data (Discovery, Pre-clinical and Clinical development)
Global key players deals (Collaborations, Licensing, Service agreements, grants, funds)
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
MENAFN06122021004694010674ID1103311801
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.